Cardiol Therapeutics Inc. Cash And Cash Equivalents
Cardiol Therapeutics Inc. (CRDL) had Cash And Cash Equivalents of CAD 21.42 million as of 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2026-03-31
- 2025-12-31: Cash And Cash Equivalents 21.42M CAD.
- 2024-12-31: Cash And Cash Equivalents 30.58M CAD.
- 2023-12-31: Cash And Cash Equivalents 34.93M CAD.
- 2022-12-31: Cash And Cash Equivalents 59.47M CAD.
| Period end | Cash And Cash Equivalents |
|---|---|
| 2025-12-31 | 21.42M CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | 30.58M CAD 40-F · filed 2026-03-31 |
| 2023-12-31 | 34.93M CAD 40-F · filed 2026-03-31 |
| 2022-12-31 | 59.47M CAD 40-F · filed 2025-03-31 |
| 2021-12-31 | 83.90M CAD 20-F · filed 2024-04-01 |
| 2020-12-31 | 14.03M CAD 20-F · filed 2024-04-01 |
| 2019-12-31 | 6.96M CAD 20-F · filed 2023-03-29 |